Drake Maye might be the NFL’s MVP through 10 weeks, but there’s more than just that going right for the Patriots. The 2025 ...

In a phase 1 trial, a gene-editing therapy that targets ANGPTL3 was associated with few serious adverse events and at higher ...

The distress that Will Bynum, MD, later recognized as shame settled over him nearly immediately. Bynum, then in his second year of residency training as a family medicine physician, was wrapping up a ...

Studies examining the effects of activity-based interventions haven’t required post-exertional malaise as a core criterion ...

Alfred University hosted the AUEnergy Conference on Thursday, Oct. 23. The event, themed “Emerging Technology for a Resilient ...

Immunocore reports third quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $103.7 million in ...

Tyee contributor Christopher Guly is an Ottawa-based journalist and a member of the Canadian Parliamentary Press Gallery. “I just want to live through 2026,” said David Suzuki in a recent interview ...

During her 2025 State of the School address, Allison Brashear, MD, MBA, evoked the image of a mighty oak tree when describing the current state of the Jacobs School of Medicine and Biomedical Sciences ...

In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel ...

GeneDx , a leader in delivering improved health outcomes through genomic insights, today announced it will unveil research findings during four key sessions at the 2025 National Society of Genetic ...

The sequel to Catherine Newman’s best-selling novel is another witty portrayal of family life and the challenges of being caught between two generations.

It's been a heck of a year in academia. This podcast miniseries, in partnership with WNYC's On The Media, examines the moral calculus universities face in dealings with the Trump administration.